Cure Pharmaceutical Holding Corp. | Business Finance | Business Contracts

Guaranty, dated July 22, 2022, by and between the Company and Buyer (Filed With SEC on July 28, 2022)

Promissory Note, dated July 22, 2022, issued by Buyer for the benefit of CURE Pharmaceutical (Filed With SEC on July 28, 2022)

Asset Purchase Agreement, dated July 22, 2022, by and between CURE Pharmaceutical and Buyer (Filed With SEC on July 28, 2022)

Forbearance Agreement (Filed With SEC on January 7, 2022)

Consent and Waiver Agreement, dated February 25, 2021, by and between the Company and Ionic Ventures, LLC (Filed With SEC on February 25, 2021)

Registration Rights Agreement (Filed With SEC on November 2, 2020)

Secured Promissory Note (Filed With SEC on November 2, 2020)

Note Purchase Agreement (Filed With SEC on November 2, 2020)

Series B Convertible Note (Filed With SEC on November 2, 2020)

Series A Convertible Note (Filed With SEC on November 2, 2020)

Security Purchase Agreement (Filed With SEC on November 2, 2020)

Secured Promissory Note, dated September 25, 2020, by and between CURE Pharmaceutical Holding Corp. and Ionic Ventures, LLC (Filed With SEC on September 30, 2020)

Secured Promissory Note (Filed With SEC on July 28, 2020)

Release, Waiver and Amendment (Filed With SEC on June 9, 2020)

Amendment to Warrants to Purchase Common Stock (Filed With SEC on June 9, 2020)

Specimen common stock certificate (Filed With SEC on March 30, 2020)

Convertible Promissory Note dated November 12, 2019 (Filed With SEC on November 14, 2019)

Convertible Demand Note Issued by Cure Pharmaceutical Holding Corp. to Chemistry Holdings, Inc (Filed With SEC on April 1, 2019)

Securities Purchase Agreement dated December 14, 2018 (Filed With SEC on January 7, 2019)

Cure Pharmaceutical Holding Corp. (54) | Business Finance (19)